Genetic Testing to Improve Management of Patients Undergoing Breast Biopsy
NCT06060561 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2025-08-29
Summary
This study evaluates genetic testing to improve risk assessment and advance efforts to develop precision management for breast cancer by studying saliva samples for genotyping and evaluate associations with pathologic diagnoses and detailed pathologic and radiologic features.
Conditions
- Breast Carcinoma
Interventions
- OTHER
-
Non-Interventional Study
Non-interventional study
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Mark E. Sherman, M.D. · Mayo Clinic
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-05-30
- Primary Completion
- 2028-06-30
- Completion
- 2028-06-30
Countries
- United States
Study Locations
More Related Trials
-
Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer
NCT02470819 ·Status: WITHDRAWN ·Phase: NA
-
Cancer Genetic Testing in Ethnic Populations
NCT04475640 ·Status: RECRUITING ·Phase: NA
-
Implementation of Population Cancer Genetic Services in Federally Qualified Health Centers (FQHC)
NCT05664867 ·Status: RECRUITING ·Phase: NA
-
Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
NCT00579163 ·Status: ACTIVE_NOT_RECRUITING
-
Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer
NCT04067960 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Genetic Testing for Men With Metastatic Prostate Cancer
NCT03503097 ·Status: TERMINATED
-
A Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services
NCT02517554 ·Status: COMPLETED
-
Clinical Outcomes in Hereditary Cancer
NCT00580021 ·Status: WITHDRAWN
-
Biomarkers in Tissue Samples From Patients With Ductal Breast Carcinoma in Situ
NCT01132560 ·Status: COMPLETED
-
INTERogating Cancer for Etiology, Prevention and Therapy Navigation
NCT06008392 ·Status: RECRUITING
-
Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome
NCT04508764 ·Status: TERMINATED ·Phase: NA
-
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
NCT01034033 ·Status: RECRUITING
-
Physicians Survey on Genetic Testing
NCT00341107 ·Status: COMPLETED
-
Interest and Impact of Skin Cancer Genetic Testing
NCT02941900 ·Status: COMPLETED
-
A Registry for Hereditary Cancer Risk Assessment and Genetic Testing
NCT04015102 ·Status: COMPLETED
-
An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test Results
NCT05420064 ·Status: RECRUITING ·Phase: NA
-
Transcriptomes Breast, Ovarian and Leukocyte Hereditary Genes Predisposing to Breast and / or Ovarian Cancer
NCT02560818 ·Status: COMPLETED ·Phase: NA
-
Markers for Predicting Risk of Breast Cancer in Women of Different Races
NCT02574546 ·Status: WITHDRAWN
-
Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal
NCT05530759 ·Status: RECRUITING
-
Exploring Men s Prostate Cancer Genetic Risk Perceptions
NCT06764992 ·Status: COMPLETED
-
Collecting and Storing Blood Samples From Patients With Cancer
NCT00900120 ·Status: WITHDRAWN
-
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
NCT03707574 ·Status: COMPLETED
-
Evaluating Microarray Pharmacogenetic Testing in Cancer Patients
NCT06489041 ·Status: RECRUITING ·Phase: NA
-
Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia
NCT01653613 ·Status: UNKNOWN
-
Molecular and ctDNA Characterization of High-Risk Endometrial Cancer
NCT07062016 ·Status: RECRUITING